News

January 05, 2007

UCSF diabetes clinical nurse specialist Mary Sullivan is quoted in this story on how specially trained dogs can pick up the scent of low blood sugars, as reported in the San Francisco Chronicle.

January 04, 2007

John Baxter, MD and Paul Webb, PhD are focused on studying the thyroid hormone which regulates overall metabolic rate, heart function and cholesterol and triglyceride levels. Elevated levels of the thyroid hormone leads to increases in metabolic rate and associated rapid weight loss, and also improves cholesterol and triglyceride balance – yet may also produce increased heart rate and arrhythmias.

January 04, 2007

CIRM, the voter-established institute created by Prop 71, awarded $12.1 million in grants to cover the first year of three-year training fellowships. UCSF received 16 grants totaling just over $1.1 million. The number of applications received was sizeable, as reported by the San Francisco Business Times

June 27, 2006

Dr. Michael German has been appointed to this new chair, which was generously funded through donations from long-time UCSF volunteer leader, Chara Schreyer and her Kadima Foundation.

June 09, 2006

April's issue of Journal of Clinical Investigation reported that UCSF’s Dr. Jeffrey Bluestone and his collaborators Matthias von Herrath and Damien Bresson at the La Jolla Institute for Allergy and Immunology and Kevan Herold of Columbia University have successfully used a new treatment approach to reverse recent onset type 1 diabetes in laboratory animals.

June 09, 2006

Therapeutic cures for diabetes may eventually range from regeneration techniques in which islets are produced endogenously, to interventions like the transplantation of islets from donors, animal sources, or engineered sources such as liver or stem cells. Regardless of the technique to replace beta cell mass, therapies won’t result in true cures without the ability to induce tolerance. In type 1 diabetes, there can be several layers of tolerance that need to be in place.

May 04, 2006

Two UCSF faculty scientists have been elected to the American Academy of Arts and Sciences, the academy announced on April 24, 2006. Jeffrey A. Bluestone, PhD, director of the UCSF Diabetes Center, and Robert W. Mahley, MD, PhD, president of the UCSF-affiliated J. David Gladstone Institutes, were among 175 new fellows elected to the academy, which includes among its members prominent scientists, scholars, artists, business leaders and public policy experts.

April 26, 2006

Christian Vaisse, MD, PhD, studies weighty matters - the genetics of obesity. He has identified a mutated gene that is responsible for extreme obesity, at least in a rare and unfortunate few. Moreover, Vaisse, an endocrinologist and associate professor with the Diabetes Center at UCSF, has recently made a patentable discovery that may one day lead to new drug treatments. So, given his success, you might expect Vaisse to be overly optimistic about genetic fixes for fat. He's not.

December 05, 2005

Using a new form of microscopy to penetrate living lymph nodes, UCSF scientists have for the first time viewed immune cells at work, helping clarify how T cells control autoimmunity.

August 22, 2005
An editorial by Dr. Stephen Gitelman: I am often asked the question, “Where is the cure for diabetes?” As a pediatrician, I think the ultimate cure for diabetes will be prevention. Why can’t we prevent someone from getting diabetes in the first place? To answer that, we need to first determine if we can predict who is going to get type 1 diabetes.
 
August 22, 2005
Diabetes Center researcher and stem cell expert Dr. Matthias Hebrok, PhD has been picked to help lead an international “dream team” of researchers that will search for ways of coaxing beta cells to regenerate themselves.
 
July 06, 2005

UCSF was the fourth-largest recipient of National Institutes of Health (NIH) research dollars in 2004, receiving a total of $438.8 million from all awards in the nationally competitive process, according to new rankings released by NIH. The ranking covers research grants, awards and contracts. UCSF’s School of Dentistry, School of Nursing and School of Pharmacy each ranked first nationally for 2004, as they have in recent years.

July 04, 2005

A publication in the June issue of the scientific journal Diabetes showed that a 2-week therapy with the drug hOKT3gamma1(Ala-Ala) slows the progression of type 1 diabetes for at least two years after treatment.

Pages